CM
BIO icon

Castleark Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Castleark Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,980
Closed -$5.32M – 373
2018
Q3 		$5.32M Sell
16,980
-1,510
-8% -$469K 0.15% 190
2018
Q2 		$5.33M Sell
18,490
-1,565
-8% -$432K 0.16% 187
2018
Q1 		$5.01M Buy
20,055
+775
+4% +$197K 0.16% 182
2017
Q4 		$4.6M Buy
+19,280
New +$4.67M 0.14% 200

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Castleark Management's BIO Position: Q4 2018 in Review

Castleark Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2018, closing a stake of 16,980 shares — an estimated $5.32M sold.

Castleark Management first reported a position in BIO in Q4 2017 and held it in 4 quarters. The position peaked at $5.33M in Q2 2018. 329 funds tracked by Wall St. Rank hold BIO as of Q4 2018.

  • Castleark Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2018 after selling out during the quarter.
  • Castleark Management sold 16,980 Bio-Rad Laboratories Class A shares in Q4 2018, an estimated $5.32M.
  • Castleark Management first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 4 quarters.
  • Castleark Management's Bio-Rad Laboratories Class A position peaked at $5.33M in Q2 2018.
  • 329 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2018.

Based on Castleark Management's 13F filing for Q4 2018, filed 12 Feb 2019.